LWM
MDT icon

LeConte Wealth Management’s Medtronic MDT Stock Holding History

LeConte Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$226K Sell
2,606
-149
-5% -$14.3K 0.15% 126
2025
Q4 		$265K Buy
2,755
+239
+9% +$23.2K 0.17% 94
2025
Q3 		$240K Buy
+2,516
New +$231K 0.16% 102

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LeConte Wealth Management's MDT Position: Q1 2026 in Review

LeConte Wealth Management reduced its Medtronic (MDT) stake by 5.4% in Q1 2026, selling an estimated $14.3K and leaving 2,606 shares worth $226K. The position accounts for 0.15% of the portfolio, ranked #126.

LeConte Wealth Management first reported a position in MDT in Q3 2025 and has held it in 3 quarters since. The position peaked at $265K in Q4 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • LeConte Wealth Management held 2,606 shares of Medtronic worth $226K as of Q1 2026.
  • LeConte Wealth Management sold 149 Medtronic shares in Q1 2026, an estimated $14.3K.
  • Medtronic made up 0.15% of LeConte Wealth Management's portfolio in Q1 2026, its #126 holding.
  • LeConte Wealth Management first reported a position in Medtronic in Q3 2025 and has held it in 3 quarters since.
  • LeConte Wealth Management's Medtronic position peaked at $265K in Q4 2025.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on LeConte Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.